In vitro inflammatory multi-cellular model of osteoarthritis

Area of Science:

• Biomedical Engineering
• Cell Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a debilitating joint disease driven by complex inflammatory processes involving chondrocytes and macrophages.
• Current OA treatments are limited, necessitating novel therapeutic strategies.
• Understanding cell-cell interactions is crucial for developing effective OA interventions.

Purpose of the Study:

• To develop and utilize a multi-cellular in vitro OA model to study inflammatory interactions.
• To characterize OA progression in response to varying inflammatory stimuli.
• To evaluate the efficacy of potential OA therapeutics, dexamethasone (DEX) and mesenchymal stromal cells (MSCs).

Main Methods:

• Compared responses of isolated macrophages, chondrocytes, and co-cultures to low (IL-1) or high (IL-1/TNF) inflammation.
• Assessed treatment effects of DEX and MSCs using gene expression and secretory profiles.
• Analyzed changes in inflammation and chondrocyte function.

Main Results:

• Inflamed chondrocytes exhibited an OA-like phenotype with increased pro-inflammatory markers and matrix degradation enzymes.
• MSC treatment reduced macrophage inflammation but not chondrocyte inflammation without macrophages.
• Dexamethasone directly attenuated chondrocyte inflammation.

Conclusions:

• Multi-cellular interactions are critical for understanding OA pathogenesis.
• The developed OA model and gene expression panel offer a comprehensive approach for biomarker discovery and treatment evaluation.
• Therapeutic strategies targeting OA should consider the specific cellular context and interactions.